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Abstract
In the NOD mouse, the incidence of type-1 diabetes is thought to be influenced by the degree of cleanliness of the mouse
colony. Studies collectively demonstrate that exposure to bacterial antigen or infection in the neonatal period prevents
diabetes [1,2,3,4,5,6,7,8,9,10], supporting the notion that immunostimulation can benefit the maturation of the postnatal
immune system [11]. A widely accepted extrapolation from this data has been the notion that NOD mice maintained under
germ-free conditions have an increased incidence of diabetes. However, evidence supporting this influential concept is
surprisingly limited [12]. In this study, we demonstrate that the incidence of diabetes in female NOD mice remained
unchanged under germ-free conditions. By contrast, a spontaneous monoculture with a gram-positive aerobic spore-
forming rod delayed the onset and reduced the incidence of diabetes. These findings challenge the view that germ-free
NOD mice have increased diabetes incidence and demonstrate that modulation of intestinal microbiota can prevent the
development of type-1 diabetes.
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Introduction
The development of the postnatal immune system is guided by the
interactions of lymphocytes with self-MHC/peptide ligands derived
from our body’s own tissues and those from the environment, such as
the commensal microbial flora of the gastrointestinal tract and the
diet. The important role of the gastrointestinal microbiota has been
emphasized by the evidence of reduced intestinal lymphatic tissue
a n du n d e r d e v e l o p e dl y m p h o i do r g a n si ng e r m - f r e em i c e
[13,14,15,16]. The interplay between the host immune system and
commensal bacteria is dynamic and continuous since the size and
cellularity of gastrointestinal lymphoid tissues recover following
selective colonization of germ-free animals [13,14]. Studies on local
immune function demonstrate that IgA secreting plasmablasts are
reduced in germ free mice [17] and the induction of commensal
specific IgA [18] has been shown to occur in response to current
bacterial exposure [19]. The molecular basis for the influence of
commensal bacteria on host immune function remains incompletely
understood, but recent studies have revealed a critical role for the
nucleotide-binding oligomerization domain containing 1 (NOD1)
protein [20] and bacterial polysaccharide [21].
The way in which antigenic stimulation guides the development
and maintenance of a healthy immune system is of fundamental
importance to our understanding of immunological tolerance. In
the non-obese diabetic (NOD) mouse strain, the target pancreatic
insulin producing beta cells are attacked and destroyed by
activated immune cells, leading to type-1 diabetes. Several
infectious, and non-infectious agents are known to prevent type-
1 diabetes in NOD mice. They include; persistent viral infection
(MHV [1], LCMV [2]), mycobacterial infection [3], bacterial
antigens [4,5]; Hsp65 [6,7,8] and complete (heat-killed mycobac-
terium-containing) Freunds adjuvant (CFA) [9,10]. Stimulation
with adjuvant containing bacterial extracts in the neonatal period
is known to prevent diabetes and imparts qualitative and
quantitative changes in the immune cell compartments that lasts
throughout adulthood [9,22]. There has been a number of
hypotheses presented that could account for the protective effect of
immunostimulation such as a change in the cytokine milieu [23]
and the increase in T cell numbers or populations of regulatory T
cells [5,22,24,25,26].
Thus, the incidence of type-1 diabetes in NOD mice is thought
to reflect the degree of cleanliness of the colony. A widely accepted
extrapolation from these data has been that NOD mice
maintained under germ-free conditions have an increased
incidence of diabetes. However, there is little evidence to support
this view [12].
Materials and Methods
A germfree caesarean derivation was performed on NOD mice
using 10females and 5 males. Ceasarean-derived micewereweaned
onto sterile dams and housed in sterile isolators to maintain
germfree status and fed an endotoxin free NIH31-M diet, designed
to provide appropriate nutrition after being autoclaved http://
www.taconic.com/wmspage.cfm?parm1=292 until thirty weeks of
ageatTaconicFarmsbreedingfacility,Germantown,NY,USA.All
supplies were sterilized and entered into the isolator using strict
aseptic techniques. Mice underwent monthly microbiological
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anaerobic organisms (for a complete list of agents see http://www.
taconic.com/wmspage.cfm?parm1=265). Urine glucose was mea-
sured every one or two weeks and mice with frank glucosuria -two
consecutive reading of 4+ (estimated at 55 mmol/L urine glucose)
were considered diabetic. Control female NOD mice were housed
under specific pathogen-free (SPF) conditions at Taconic and the
Scripps rodent colony, which were handled in accordance with the
TSRI Animal Care and Use Committee, which approved this study
(A3194-01). Blood glucose values (BGV) were determined using
Glucofilm blood glucose strips (Miles Diagnostic, Elkhart, IN). Mice
were considered diabetic following two consecutive blood glucose
readings above 18 mmol/L.
Results and Discussion
We sought to determine the influence of intestinal microbiota on
the incidence of type-1 diabetes in NOD mice. To our surprise, the
incidence of type-1 diabetes in female germ free NOD mice (n=22)
was indistinguishable from that of NOD mice housed under SPF
conditions in our colony (n=20) (Figure 1, p.0.6696) or the 80%
incidence of female NOD mice housed under SPF conditions at
Taconic (Figure 1, p,0.78). However, our findings also indicated
that intestinal microflora had the capacity to influence the
development of type-1 diabetes. In one cohort of NOD mice
(n=22) housed in a separate isolator, a spontaneous contamination
with a gram-positive aerobic spore-forming rod (that was subse-
quently typed as Bacillus cereus) was detected at week 16. These mice
exhibited a delayed onset, and reduced incidence of clinical disease
(p,0.001) during the 30-week study period (Figure 1).
The NOD genetic background is one important factor
contributing to the normal development of T1D in female NOD
mice in the absence of known intestinal microbiota. However, the
critical influence of the environment was highlighted by the reduced
incidence of diabetes following spontaneous monoculture with
aerobic, spore-forming, bacteria. Diet has a well-established role in
the development of T1D in NOD mice [27,28,29] and the observed
reductionofdiabetesislikelytohavereflecteddiabetespromoting as
well as regulatory factors from the interactions of dietary
components, restricted microbiota and the immune system. The
extent to which the monoculture influenced the development of
immune regulatory networks, as has been suggested in MyD88-/-
NOD mice [30], remains unknown. However, since restricted flora
limit the growth of other organisms through local competition, our
findings did not exclude the possibility that germ-free mice harbour
microorganisms that play a role in diabetes development but defy
current methods of detection.
Taken together, these findings debunk the myth that germ-free
NOD female mice have increased diabetes incidence and support the
notion that modulation of intestinal microbiota can have beneficial
effects on the development of autoimmune diabetes. Future
e x a m i n a t i o no ft h ei n f l u e n c eo fa na r r a yo fc o m m e n s a lm i c r o b i o t a
on diabetes incidence offers the potential for non-invasive approaches
for individuals at risk of developing type-1 diabetes.
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